The Chloroquine Wars Part XXI
17/05/2021 No Comments
Dr. Pierre Kory explain both the case that ivermectin (IVM) effectively prevents or treats COVID-19, and also how and why that information is withheld by public health officials.
Dr. Pierre Kory explain both the case that ivermectin (IVM) effectively prevents or treats COVID-19, and also how and why that information is withheld by public health officials.
But while political psychology did its thing, making HCQ a no go zone for many physicians, Tyson and his staff simply treated patients according to whatever seemed to work, using HCQ as a primary option. And work it did.
Both Goa and Karnataka are rolling out mass Ivermectin programs in a bid to reduce infection, transmission, and death rates associated with COVID-19. TrialSite reported two days ago that the State of Goa embraced the national Ivermectin guidelines, and as reported in The Mint and other outlets, Vishwajit Rane, Goa’s Health Minister, declared that all people 18 years and up would have access to the generic drug regardless of COVID-19 status in an aggressive bid to lower infection rates and total deaths associated with SARS-CoV-2.
Today, the health experts tasked at the political levels of the United States (and by chance those nations closest to its sphere of influence) are failing us by dismissing an avalanche of evidence of effective empiric COVID-19 treatments, primarily at the early stages of disease.
Source: Francesoir Italy has been talked about a lot since the start of the Covid crisis in 2020 with first of all a significant mortality
We are very honored to present this interview of Dr Vladimir Zelenko, the father of outpatient treatment for COVID-19 in North America. Dr Zelenko shares his own experience with COVID-19 as a patient, as he is recovering from a severe form of the disease.
He also talks about his cancer and how he was able to go through this dramatic episode of his life. Then, he presents his perspectives about outpatient treatment as practiced today and the evolution of the pandemic, among other topics.
Famous actor, Louis Gosset Jr. and his physician, Dr. Bruce Boros, share their experience with a life saving treatment against Covid.
Significant QT prolongation was not observed during the follow‐up period compared with the baseline values in the present study. No ventricular arrhythmias, second and third‐degree heart blocks, or severe pauses were recorded during the treatment period.
At this point, continuing the use of Ivermectin has proven safe and we see no reason to stop this drug, which seems to have not only inhibited our second wave but so far prevented a third one.
“The Minister of Health, Marcelo Queiroga, has announced that he will soon launch a protocol of drugs to be used in the treatment against Covid-19. ”
This guide, which should guide health workers, has, as likely drugs, hydroxychloroquine and ivermectin.
Today, most leading doctors in India are themselves not promoting the Ministry of Health guidelines that includes the use of hydroxychloroquine, ivermectin and inhaled budesonide.
n a recent interview, Dr. Stone recently shared that while the death rate climbed much higher in January, again peaking at 70 deaths on the 25th of that month, Official authorization for the use of ivermectin was granted a day later.
A month later, the number of deaths fell to zero. Again, the correlation here along with Dr. Stone’s direct clinic experience is ivermectin sales. Over 500,000 doses of the generic, FDA-approved drug were administered from December through February. This compares to 1,057 bottles turned over in January 2020.
If you were going to try and design a drug, for the disease that we call COVID-19, you would want something with heavy anti-viral properties, as well as anti-inflammatory properties.
When you think about that, it’s hard to come up with a better drug for Covid than ivermectin. It literally does both of those things simultaneously, and it’s one of the safest drugs known to man.
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. Prof. Héctor Carvallo shares his experiences with using ivermectin for long covid in Argentina.
The International Ivermectin for Covid Conference: Dr. Wasif Khan presents his published ivermectin trial and his experience with using ivermectin in Bangladesh.
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. Prof. Pierre Kory discusses current protocols for covid-19 prevention and treatment.
The International Ivermectin for Covid Conference: Professor Eli Schwartz shares data and conclusions from his Israeli randomised controlled trial of ivermectin in mild to moderate covid-19.
British Ivermectin Recommendation Development (BIRD) is campaigning for UK approval for ivermectin to help it beat Covid. Dr Tess Lawrie wraps up their first International ivermectin conference. This is her powerful and impassioned speech.
As Head of the Department of Medical Ethics and Law, Medical Faculty, University of Maribor, Slovenia, Prof. Matjaž Zwitter presents current ethical issues around ivermectin for covid-19. His two papers on ivermectin for Covid-19, as published in Slovenian medical journal Isis and in leading newspaper Delo stirred a vivid debate among medical and lay community, hopefully leading to a change in current medical practice.
Dr. Manjul Medhi shares his front-line experiences in treating acute and long covid including using ivermectin in patients at risk of disseminated strongyloides infection.
The first-ever conference focusing on the use of ivermectin (IVM) as a prophylaxis and treatment for covid-19 was held online April 24-25 2021. Dr Tina Peers, UK GP describes her real-world experiences treating Long Covid.
The International Ivermectin for Covid Conference: Dr. David Chesler shares his experience of using ivermectin to prevent and treat covid-19 infection amongst care home residents.
Dr. Tess Lawrie presents the latest systematic review evidence from RCTs and a selection of resource, equity, acceptability and feasibility considerations related to ivermectin use for COVID-19
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic. In this talk, speaker Dr. Mobeen Syed provides an overview of ivermectin and how it works against covid-19.
So, what’s different between Maharashtra and Delhi with respect to the rest of India and South Asia? Instead of relying on HCQ and IVM, many doctors and health officials in Maharashtra and Delhi pushed the expensive and profitable remdesivir drug. Due to its cost and recommended time of usage, remdesivir is not used either as a prophylaxis or for early outpatient treatment. And unlike the cheap and easy-to-produce HCQ and IVM, remdesivir is difficult to replace when it runs out.
HCQ is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 235 studies to date is estimated to be 1 in 6 quadrillion (p = 0.00000000000000018).
Early treatment is most successful, with 100% of 29 studies reporting a positive effect (13 statistically significant in isolation) and an estimated reduction of 65% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.35 [0.25-0.50].
92% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.0017.
With a surge of SARS-CoV-2 infections and a vaccination drive totaling 1.3 million, the nation’s leadership faces an uphill battle when factoring in their total population of 108 million. Hence the growing interest in ivermectin and the request of hospitals for access to the drug for compassionate use.
The sales of hydroxychloroquine in the Chinese market have been rising steadily, from CNY 258 million in 2016 to CNY 343 million in 2020, with a CAGR of 7.34% from 2016 to 2020. In 2020, China’s sales of hydroxychloroquine were CNY 343 million, a slight increase of 0.71% than 2019.
It is high time to open our eyes, to hold our governments to account, and to fundamentally reform a system that has been misled by the interests of the all-powerful pharmaceutical industry. ”
Every viral illness starts that way. The more it’s allowed to progress, the more it takes over the cells and replicates itself. That’s why this virus absolutely had to be treated early to prevent those damages. Primarily what has killed people with COVID is a delay to treatment, and allowing the exaggerating inflammatory response and blood clotting response to take hold in the body.
MANILA, Philippines — Another private hospital was given a compassionate special permit (CSP) to use Ivermectin as treatment for COVID-19 patients, the Food and Drug Administration (FDA) said yesterday.
This disease is very manageable & easy to treat. They censor us because we tell the truth – they don’t want us to treat people. They want to sell vaccines.
In an interview with Alan Jones, Craig Kelly MP discusses the vaccine rollout mishaps and yet again, rightfully points out the myriad of medical specialists around the world who support the use of ivermectin for the prophylaxis and treatment of their Covid-19 patients with the backup of extensive positive data.
Source: The New American Author: Annalisa Pesek Calls are increasing for investigations into Dr. Anthony Fauci’s intentional suppression of inexpensive and easily accessible, life-saving treatments for COVID-19.
Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.
FLCCC Weekly Update: “Big Science vs Little Science”—April 14, 2021 Drs. Jose Morgenstern and Jose Redondo of the Dominican Republic share their new ivermectin study and tell the story of how they discovered the efficacy of ivermectin in April, 2020.
Hydroxychloroquine also can act as an oral hypoglycemic agent, as patients with diabetes taking hydroxychloroquine for rheumatologic diseases had a significant reduction in hemoglobin A1c when compared to methotrexate,40 and thus can serve to reduce hyperglycemia, a possible COVID‐19 risk factor for disease severity.
Dr. Steven Hatfill, infectious disease expert, says the medical bureaucracy blocked an effective treatment in hydroxychloroquine so they could push through experimental vaccines.
Ivermectin, a medicine for parasites, has been around for four decades. While not authorized for use against COVID-19, dozens of studies show materially positive results. At well-established human dosage levels, the drug is safe: hundreds of millions of people are treated with it every year mostly in the tropics for various parasite-borne diseases, such as River Blindness in Nigeria.
The authors emphasize the historically significant & relevant role of empiric treatment in an attempt to reduce death. Doing nothing is not good medicine.